
Benzimidazole and Imidazole Derivatives
Benzimidazole is a compound consisting of a benzene ring fused to an imidazole ring, a five-membered structure containing two nitrogen atoms. Benzimidazole derivatives, such as albendazole, are known for their antiparasitic and antifungal activity, used in the treatment of parasitic infections and certain parasitic diseases in animals and humans. Imidazole, on the other hand, is a five-membered structure with two nitrogen atoms found in various biologically active compounds. Imidazole derivatives, such as metronidazole, have antimicrobial and antiparasitic properties. These compounds are also used in the pharmaceutical industry for treating bacterial infections, parasitic diseases, and some fungal infections, as well as in organic chemistry as catalysts.
At CymitQuimica, we offer high-purity benzimidazoles and imidazoles for research in medicinal chemistry, pharmacology, and biotechnology.
Found 10345 products of "Benzimidazole and Imidazole Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Pantoprazole N-oxide sodium
CAS:<p>Pantoprazole N-oxide sodium is a custom synthesis drug product that is being developed as an impurity standard in the synthesis of Pantoprazole. The compound is also used as a pharmacopoeia analytical standard and a HPLC standard.</p>Formula:C16H15F2N3O5S·NaPurity:Min. 95%Color and Shape:PowderMolecular weight:422.36 g/molN-(2-Phenethyl)benzamide
CAS:<p>N-(2-Phenethyl)benzamide (NPEB) is a molecule that belongs to the group of reactive molecules. It has been shown to be toxic to gram-positive bacteria, such as Staphylococcus aureus and Bacillus subtilis, but not gram-negative bacteria such as Escherichia coli. NPEB also has been shown to have locomotor activity in animals, which may be due to its ability to inhibit the mitochondrial electron transport chain and inhibit ATP production. NPEB's biological properties are well characterized. FTIR spectroscopy showed that this molecule has an amide functional group and is a small molecule with a molecular weight of 176.4 g/mol. This molecule was also found to be able to bind to mitochondria in animals.</p>Formula:C15H15NOPurity:Min. 97 Area-%Color and Shape:PowderMolecular weight:225.29 g/molDihydroxy diketo atorvastatin impurity
CAS:<p>Dihydroxy diketo atorvastatin impurity is a synthetic impurity that is generated by the metabolism of atorvastatin. This drug product is an analytical standard for the determination of purity, and can also be used to develop high purity drugs.</p>Formula:C26H24FNO5Purity:Min. 95%Molecular weight:449.47 g/mol6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
CAS:<p>6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is a metabolite that can be found in the urine and blood of humans. It has been shown to have cytotoxic effects on human lymphocytes and erythrocytes. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is used as an impurity standard for HPLC analysis and as a reference compound for pharmacopoeia. This chemical is also used in the synthesis of some drugs. 6-(2,4-Dichlorophenyl)-1,2,4-triazine-3,5-diamine is not listed in any pharmacopoeia or natural product database.</p>Formula:C9H7Cl2N5Purity:Min. 95%Color and Shape:White PowderMolecular weight:256.09 g/mol(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
CAS:<p>(1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline is a drug used to treat depression. It is an antidepressant drug that inhibits the reuptake of serotonin and norepinephrine in the brain by blocking their transport into the nerve cells. The drug acts as a weak inhibitor of monoamine oxidase (MAO). It also has an effect on bladder function. This compound is synthesized from 1-phenyl-2,5-dihydrothiazole by way of a sequence of reactions that includes the formation of an amine salt via reaction with phosphorus pentoxide and chloroacetic acid followed by conversion to the chloride with thionyl chloride.</p>Formula:C15H15NPurity:Min. 95%Color and Shape:White PowderMolecular weight:209.29 g/mol2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt
<p>2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt is a white to off-white crystalline powder. It is soluble in water and sparingly soluble in alcohol. This product is used as an analytical standard and has been found to be a metabolite of the drug clozapine. 2-(3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt has also been found to be an impurity in the drug product lamotrigine.</p>Formula:C24H29NO5•NaPurity:Min. 95%Molecular weight:434.49 g/mol2-Hydroxy-2,2-bis(2-thienyl) acetic acid
CAS:<p>2-Hydroxy-2,2-bis(2-thienyl) acetic acid is a long-acting bronchodilator that can be administered by inhalation. It has been used in the clinical development of medicines for the treatment of asthma and chronic obstructive pulmonary disease. 2-Hydroxy-2,2-bis(2-thienyl) acetic acid is chemically related to pyridinium compounds. It is a potent inhibitor of muscarinic receptors and has an anticholinergic profile similar to atropine. The safety profile of this drug seems to be favourable in humans with no major side effects reported so far.</p>Formula:C10H8O3S2Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:240.3 g/molN-Desmethyl galanthamine
CAS:Controlled Product<p>N-Desmethyl galanthamine is a plant alkaloid that is found in the Huperzia serrata plant. It has been shown to have cholinergic activity and calcium binding properties. N-Desmethyl galanthamine inhibits acetylcholinesterase, an enzyme responsible for the breakdown of acetylcholine, which is a neurotransmitter. This inhibition leads to increased levels of acetylcholine, which results in increased neuron stimulation and improved memory function. N-Desmethyl galanthamine also binds to β2 nicotinic receptor sites and blocks the binding of nicotine, leading to decreased nicotine dependence.</p>Formula:C16H19NO3Purity:Min. 95%Molecular weight:273.33 g/molMethyl 2,2-dithienylglycolate
CAS:<p>Intermediate for tiotropium bromide synthesis</p>Formula:C11H10O3S2Purity:Min. 95%Color and Shape:White PowderMolecular weight:254.33 g/molRabeprazole
CAS:<p>Rabeprazole is a proton pump inhibitor that suppresses the production of stomach acid by blocking the H+/K+ ATPase enzyme. It is used for the treatment of gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome. Rabeprazole has been shown to be more effective than omeprazole in reducing gastric acid secretion in two-way crossover studies. Rabeprazole also has been shown to inhibit the growth of antibiotic-resistant strains of bacteria. In addition, rabeprazole binds to metal ions like iron and copper, which may affect its pharmacokinetics and efficacy. This drug is currently being investigated as an analytical method for determination of proton pump inhibitors in human serum and urine samples by electrochemical impedance spectroscopy (EIS).</p>Formula:C18H21N3O3SPurity:Min. 95%Color and Shape:White PowderMolecular weight:359.44 g/mol5,6-Dimethoxy-2-(4-piperidinyl)methyleneindan-1-one (donepezil impurity)
CAS:<p>5,6-Dimethoxy-2-(4-piperidinyl)methyleneindan-1-one (donepezil impurity) is an analytical standard used as a reference in HPLC assays for donepezil. It is also a metabolite of donepezil and has been found to have pharmacological activity similar to that of the parent compound. This impurity is present in donepezil drug products at levels up to 0.5%.</p>Formula:C17H21NO3Purity:Min. 95%Molecular weight:287.35 g/mol2-Hydroxybenzimidazole
CAS:<p>2-Hydroxybenzimidazole is a benzimidazole compound that is used in the treatment of nervous system diseases. It has been shown to have anti-inflammatory properties and can be used in the treatment of syncytial virus infection. 2-Hydroxybenzimidazole inhibits the production of reactive oxygen species and nitric oxide, which are involved in neurodegenerative disorders. The mechanism of action for 2-Hydroxybenzimidazole involves the formation of hydrogen bonds with hydroxyl groups on proteins. It also has been shown to reduce locomotor activity and increase sleep time in mice, which may be due to inhibition of acetylcholine release from cholinergic neurons.</p>Formula:C7H6N2OPurity:Min. 97.5 Area-%Color and Shape:Off-White PowderMolecular weight:134.14 g/molN-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide
CAS:<p>N-[5-Amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide is a pharmaceutical dosage form that is titrated to achieve the desired therapeutic effect. It is used to treat epilepsy and bipolar disorder. Lamotrigine binds to sodium channels in nerve cells and blocks their opening. This prevents the influx of sodium ions that are necessary for neuronal transmission. Lamotrigine has been shown to have an anticonvulsant effect by reducing the frequency of seizures in patients with epilepsy.</p>Formula:C16H9Cl4N5OPurity:Min. 95%Color and Shape:White Off-White PowderMolecular weight:429.09 g/molPantoprazole sulphone
CAS:<p>Pantoprazole sulphone is a proton-pump inhibitor that inhibits the production of stomach acid and protects the esophagus from damage. Pantoprazole sulphone has been shown to be effective in treating heart disease patients and reducing their risk of death. It also has biological properties, including modulating the effects of bosentan, which is used to treat pulmonary arterial hypertension. Pantoprazole sulphone has been shown to be chemically stable and stereoselective, which means it binds more strongly to one site than another. Clinical pharmacology studies have found that pantoprazole sulphone has no effect on abomasal motility or gastric emptying time.</p>Formula:C16H15F2N3O5SPurity:Min. 97 Area-%Color and Shape:PowderMolecular weight:399.37 g/molVarenicline
CAS:<p>Varenicline (CP 526555) is a selective partial agonist of the α4β2 nAChR and a full agonist of the α3β4 nAChR and α7 nAChR.</p>Formula:C13H13N3Purity:99.76%Color and Shape:SolidMolecular weight:211.264-Bromo-1-trityl-1H-imidazole
CAS:Formula:C22H17BrN2Purity:98%Color and Shape:SolidMolecular weight:389.296Methyl 1H-indazole-7-carboxylate
CAS:Formula:C9H8N2O2Purity:97%Color and Shape:Solid, Pale yellow solidMolecular weight:176.1751-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
CAS:Purity:98%Molecular weight:258.1300049Oxazole-4-carbonitrile
CAS:Formula:C4H2N2OPurity:97%Color and Shape:Low Melting SolidMolecular weight:94.073(S)-4-Formyl-2,2-dimethyl-oxazolidine-3-carboxylic tert-butyl ester
CAS:Formula:C11H19NO4Purity:95%Color and Shape:LiquidMolecular weight:229.276(1-Methyl-2-nitro-1H-imidazol-5-yl)methanol
CAS:Formula:C5H7N3O3Purity:95%Color and Shape:SolidMolecular weight:157.1294-(1H-Imidazol-1-yl)benzoic acid
CAS:Formula:C10H8N2O2Purity:97%Color and Shape:White powderMolecular weight:188.1861H-Benzo[d]imidazole
CAS:Formula:C7H6N2Purity:97%Color and Shape:Solid, CrystallineMolecular weight:118.1391H-Indazole-4-carbaldehyde
CAS:Formula:C8H6N2OPurity:97%Color and Shape:SolidMolecular weight:146.149(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-(1H-imidazol-5-yl)propanoate
CAS:Formula:C12H19N3O4Purity:95%Color and Shape:SolidMolecular weight:269.3016-FLUORO-5-INDAZOLECARBOXYLIC ACID METHYL ESTER
CAS:Formula:C9H7FN2O2Purity:98%Molecular weight:194.1651,2-Dimethyl-5-nitroimidazole
CAS:Formula:C5H7N3O2Purity:95%Color and Shape:SolidMolecular weight:141.134-methyl-1H-benzimidazol-2-amine hydrobromide
CAS:Formula:C8H10BrN3Purity:97%Molecular weight:228.0937-AMINO-5-BROMO-1H-INDAZOLE
CAS:Formula:C7H6BrN3Purity:95%Color and Shape:SolidMolecular weight:212.052-(Piperidin-3-yl)-1H-benzo[d]imidazole
CAS:Formula:C12H15N3Purity:95%Color and Shape:SolidMolecular weight:201.2736-Bromo-1,3-dimethyl-1H-indazole
CAS:Formula:C9H9BrN2Purity:98%Color and Shape:No data available.Molecular weight:225.0894-Bromo-2-methyl-2H-indazole
CAS:Formula:C8H7BrN2Purity:98%Color and Shape:LiquidMolecular weight:211.062TERT-BUTYL 3-METHYL-5-NITRO-1H-INDAZOLE-1-CARBOXYLATE
CAS:Formula:C13H15N3O4Purity:98%Molecular weight:277.284-(Chloromethyl)-1-methyl-1H-imidazole hydrochloride
CAS:Formula:C5H8Cl2N2Purity:95%Color and Shape:SolidMolecular weight:167.031-Methyl-3-octyl-1H-imidazol-3-ium bis(2,2,2-trifluoroacetyl)amide
CAS:Purity:97%Molecular weight:403.369(3-METHYL-1H-INDAZOL-6-YL)BORONIC ACID PINACOL ESTER
CAS:Formula:C14H19BN2O2Purity:98%Color and Shape:SolidMolecular weight:258.132-Bromo-1-methyl-1H-imidazole
CAS:Formula:C4H5BrN2Purity:97%Color and Shape:LiquidMolecular weight:161.0021-(Tetrahydro-2H-pyran-2-yl)-1H-imidazole-5-boronic acid pinacol ester
CAS:Formula:C14H23BN2O3Purity:95%Molecular weight:278.162-Methyl-1H-imidazole-4-carbaldehyde
CAS:Formula:C5H6N2OPurity:97%Color and Shape:SolidMolecular weight:110.116tert-butyl N-[(1S)-1-[4-(4-bromophenyl)-1H-imidazol-2-yl]-2-methylpropyl]carbamate
CAS:Purity:98%Molecular weight:394.313(1H-Indazol-5-yl)methanamine hydrochloride
CAS:Formula:C8H10ClN3Purity:97%Color and Shape:SolidMolecular weight:183.641-(3-Chloropropyl)-1,3-dihydro-2H-benzimidazol-2-one
CAS:Formula:C10H11ClN2OPurity:90%Color and Shape:SolidMolecular weight:210.661H-Benzimidazole-2-sulfonic acid
CAS:Formula:C7H6N2O3SPurity:98%Color and Shape:SolidMolecular weight:198.22-(1H-Imidazol-1-yl)acetic acid hydrochloride
CAS:Formula:C5H7ClN2O2Purity:96%Color and Shape:SolidMolecular weight:162.571H-Benzimidazole-4-carboxylic acid
CAS:Formula:C8H6N2O2Purity:97%Color and Shape:SolidMolecular weight:162.1483-Iodo-7-nitro-1H-indazole
CAS:Formula:C7H4IN3O2Purity:98%Color and Shape:SolidMolecular weight:289.032N-(2-Chloroethyl)-imidazole hydrochloride
CAS:Formula:C5H8Cl2N2Purity:95%Color and Shape:SolidMolecular weight:167.03


